Filters

AFTPH Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

AFTPH Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetAFTPH Lentiviral Vector (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Short nameAFTPH Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-Red Fluorescent-2A-Puro), AFTPH Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 25951
Gene AFTPH
Long gene name aftiphilin
Synonyms MGC33965 FLJ20080 FLJ23793 Nbla10388
Locus 2p14
Discovery year 2006-06-19
GenBank acession AB073356
Entrez gene record 54812
Pubmed identfication 14665628 15758025 15811338
RefSeq identity NM_017657
Havana BLAST/BLAT OTTHUMG00000129539

Similar products

Subscribe to our Newsletter